ArticleMolecular cancer therapeutics2010

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.

Naoko Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.